nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—Urine output increased—Ramipril—type 1 diabetes mellitus	0.0112	0.0528	CcSEcCtD
Tolvaptan—Polyuria—Ramipril—type 1 diabetes mellitus	0.0103	0.0483	CcSEcCtD
Tolvaptan—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00947	0.0445	CcSEcCtD
Tolvaptan—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00924	0.0434	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.0092	0.0432	CcSEcCtD
Tolvaptan—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00905	0.0425	CcSEcCtD
Tolvaptan—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00844	0.0397	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00823	0.0387	CcSEcCtD
Tolvaptan—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00814	0.0383	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00756	0.00961	CbGpPWpGaD
Tolvaptan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00752	0.00955	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00716	0.0091	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00711	0.00903	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00711	0.00903	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.00684	0.00869	CbGpPWpGaD
Tolvaptan—Renal failure—Ramipril—type 1 diabetes mellitus	0.00683	0.0321	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00654	0.00831	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00651	0.00826	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.0065	0.00825	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00636	0.00807	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00614	0.00779	CbGpPWpGaD
Tolvaptan—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00613	0.0288	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00612	0.00777	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00609	0.00774	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00587	0.00745	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00583	0.0074	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.0058	0.00737	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.0058	0.00737	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00576	0.00732	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00576	0.00732	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00564	0.00716	CbGpPWpGaD
Tolvaptan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00563	0.0265	CcSEcCtD
Tolvaptan—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00562	0.0264	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00546	0.00693	CbGpPWpGaD
Tolvaptan—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00543	0.0255	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00542	0.00688	CbGpPWpGaD
Tolvaptan—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00532	0.025	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00528	0.00671	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00526	0.00668	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00524	0.00666	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00522	0.00663	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00507	0.00644	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00504	0.0064	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00504	0.0237	CcSEcCtD
Tolvaptan—Malaise—Ramipril—type 1 diabetes mellitus	0.00489	0.023	CcSEcCtD
Tolvaptan—Syncope—Ramipril—type 1 diabetes mellitus	0.00487	0.0229	CcSEcCtD
Tolvaptan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00477	0.0224	CcSEcCtD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00463	0.00589	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00459	0.0216	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00458	0.00582	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—type 1 diabetes mellitus	0.00458	0.00581	CbGpPWpGaD
Tolvaptan—Discomfort—Ramipril—type 1 diabetes mellitus	0.00457	0.0215	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00455	0.00578	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—PRF1—type 1 diabetes mellitus	0.00454	0.00577	CbGpPWpGaD
Tolvaptan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00452	0.0212	CcSEcCtD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—CP—type 1 diabetes mellitus	0.00446	0.00567	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00443	0.0208	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00439	0.00557	CbGpPWpGaD
Tolvaptan—Shock—Ramipril—type 1 diabetes mellitus	0.00436	0.0205	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00436	0.00553	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00434	0.0204	CcSEcCtD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00432	0.00549	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.00432	0.00549	CbGpPWpGaD
Tolvaptan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0043	0.0202	CcSEcCtD
Tolvaptan—Anorexia—Ramipril—type 1 diabetes mellitus	0.00422	0.0199	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00402	0.00511	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.004	0.00509	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FOXP3—type 1 diabetes mellitus	0.004	0.00508	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00399	0.00507	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00398	0.00505	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00397	0.00505	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00397	0.00505	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00394	0.00501	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00394	0.00501	CbGpPWpGaD
Tolvaptan—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00385	0.0181	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00382	0.018	CcSEcCtD
Tolvaptan—Constipation—Ramipril—type 1 diabetes mellitus	0.00379	0.0178	CcSEcCtD
Tolvaptan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00365	0.0172	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00358	0.00455	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00356	0.00452	CbGpPWpGaD
Tolvaptan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.0035	0.0165	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.0034	0.00432	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00338	0.00429	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00334	0.00424	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.00332	0.00422	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00332	0.00421	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00332	0.00421	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00329	0.00418	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00328	0.00416	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00326	0.0153	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00326	0.00413	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00319	0.00405	CbGpPWpGaD
Tolvaptan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00318	0.0149	CcSEcCtD
Tolvaptan—Pruritus—Ramipril—type 1 diabetes mellitus	0.00313	0.0147	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00308	0.00392	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00306	0.00389	CbGpPWpGaD
Tolvaptan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00303	0.0143	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00301	0.00382	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00299	0.0038	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00298	0.00378	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00298	0.00378	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00296	0.00375	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00296	0.00375	CbGpPWpGaD
Tolvaptan—Dizziness—Ramipril—type 1 diabetes mellitus	0.00293	0.0138	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.0029	0.00369	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.00286	0.00363	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.0028	0.00356	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00278	0.00353	CbGpPWpGaD
Tolvaptan—Headache—Ramipril—type 1 diabetes mellitus	0.00278	0.013	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00277	0.00352	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.00275	0.0035	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00275	0.00349	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00266	0.00338	CbGpPWpGaD
Tolvaptan—Nausea—Ramipril—type 1 diabetes mellitus	0.00263	0.0124	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00259	0.00329	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00259	0.00329	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00257	0.00327	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00257	0.00326	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00251	0.00319	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.0025	0.00317	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.00242	0.00308	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00235	0.00299	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00233	0.00296	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00227	0.00289	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.00227	0.00288	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00226	0.00287	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00226	0.00287	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00225	0.00285	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.00224	0.00285	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.00218	0.00277	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.00215	0.00273	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.00214	0.00272	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.00214	0.00272	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.00208	0.00265	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00206	0.00262	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00205	0.00261	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00205	0.0026	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00205	0.0026	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00204	0.00259	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.00204	0.00259	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.00203	0.00258	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00203	0.00257	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00201	0.00255	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.00199	0.00253	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00195	0.00248	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00194	0.00246	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.00191	0.00242	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.0019	0.00241	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00189	0.00241	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00189	0.0024	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.00189	0.0024	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00188	0.00239	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00187	0.00238	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00184	0.00234	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00183	0.00232	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00178	0.00226	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00177	0.00225	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00177	0.00224	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00176	0.00223	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00176	0.00223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00176	0.00223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00175	0.00222	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00175	0.00222	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.00172	0.00219	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00172	0.00218	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00171	0.00218	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00171	0.00217	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.0017	0.00216	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00169	0.00215	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00165	0.0021	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00164	0.00209	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.00159	0.00202	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.00156	0.00198	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00148	0.00189	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00147	0.00187	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00146	0.00186	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00145	0.00185	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00144	0.00183	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00143	0.00182	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.00142	0.0018	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.0014	0.00177	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00139	0.00176	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00139	0.00176	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00139	0.00176	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00138	0.00175	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00138	0.00175	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00133	0.00169	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00132	0.00168	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00131	0.00166	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.0013	0.00165	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.00126	0.0016	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00124	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00122	0.00155	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00121	0.00154	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SST—type 1 diabetes mellitus	0.00121	0.00154	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00121	0.00153	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.00112	0.00143	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.00112	0.00142	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.00112	0.00142	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00111	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00109	0.00138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00108	0.00137	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.00107	0.00136	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00105	0.00133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00104	0.00132	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00102	0.0013	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00102	0.00129	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00101	0.00129	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00101	0.00128	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00101	0.00128	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000982	0.00125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000923	0.00117	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00092	0.00117	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000917	0.00116	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000913	0.00116	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000886	0.00113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000879	0.00112	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000846	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000841	0.00107	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00084	0.00107	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000835	0.00106	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000833	0.00106	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000823	0.00104	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000815	0.00103	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000799	0.00101	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000793	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000786	0.000998	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00078	0.000991	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000774	0.000983	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000769	0.000976	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000768	0.000976	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000763	0.000969	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000757	0.000962	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000751	0.000954	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000718	0.000912	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000646	0.000821	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000642	0.000815	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000617	0.000784	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000611	0.000776	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INS—type 1 diabetes mellitus	0.000606	0.00077	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000591	0.00075	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000588	0.000746	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000586	0.000745	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000583	0.000741	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.00058	0.000737	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000553	0.000702	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000546	0.000693	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000542	0.000688	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000535	0.00068	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000532	0.000675	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000503	0.000639	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000455	0.000577	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000454	0.000577	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000452	0.000574	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000451	0.000573	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000451	0.000572	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000448	0.00057	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000422	0.000536	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000402	0.000511	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000398	0.000505	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000382	0.000485	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.00038	0.000483	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000379	0.000482	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000358	0.000454	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000347	0.000441	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000345	0.000438	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000336	0.000427	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	0.000316	0.000401	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	0.000314	0.000399	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.00031	0.000394	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000308	0.000392	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.00027	0.000343	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000267	0.000339	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000265	0.000336	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	0.000246	0.000312	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000245	0.000311	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	0.000208	0.000264	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	0.000207	0.000263	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	0.000195	0.000247	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	0.000194	0.000246	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	0.00019	0.000241	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	0.000151	0.000192	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INS—type 1 diabetes mellitus	0.000138	0.000175	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	0.000128	0.000163	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	0.000127	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	0.000121	0.000154	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	8.51e-05	0.000108	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	7.8e-05	9.91e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	7.46e-05	9.48e-05	CbGpPWpGaD
